De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
about
Novel siRNA delivery system to target podocytes in vivoEpidermal growth factor: a new therapeutic target in glomerular disease.Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular diseaseRenal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytesAlbumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2Transcriptional landscape of glomerular parietal epithelial cells.Claudin 1 and nephrin label cellular crescents in diabetic glomerulosclerosisGalacto-oligosaccharides attenuate renal injury with microbiota modificationUrine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine.The glomerular parietal epithelial cell's responses are influenced by SM22 alpha levels.Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.Deficiency of the planar cell polarity protein Vangl2 in podocytes affects glomerular morphogenesis and increases susceptibility to injury.Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.Podocyte biology for the bedsideInvestigating mechanisms of chronic kidney disease in mouse modelsACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation.Changes in glomerular parietal epithelial cells in mouse kidneys with advanced ageSirtuin 1: A Target for Kidney Diseases.Mannose receptor 2 attenuates renal fibrosisImaging of podocyte foot processes by fluorescence microscopy.Cells of renin lineage are adult pluripotent progenitors in experimental glomerular diseaseDe novo expression of podocyte proteins in parietal epithelial cells in experimental aging nephropathy.Activated ERK1/2 increases CD44 in glomerular parietal epithelial cells leading to matrix expansion.Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosisParietal epithelial cell activation marker in early recurrence of FSGS in the transplant.Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGSA compendium of urinary biomarkers indicative of glomerular podocytopathy.The direction and role of phenotypic transition between podocytes and parietal epithelial cells in focal segmental glomerulosclerosis.Compound effects of aging and experimental FSGS on glomerular epithelial cellsWT1 in disease: shifting the epithelial-mesenchymal balance.Associations between structural and functional changes to the kidney in diabetic humans and mice.The emergence of the glomerular parietal epithelial cell.Progenitor cells and podocyte regeneration.Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.Can podocytes be regenerated in adults?Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury.Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype.Podocyturia: Potential applications and current limitations.New insights into glomerular parietal epithelial cell activation and its signaling pathways in glomerular diseases.
P2860
Q27333807-C04EF3CD-C162-4508-AD00-F8177D9330CFQ27686898-85B21EF9-791C-4031-AC5E-90AA51EFB915Q30411457-D42738AB-5386-4F3B-A1CD-BFDEB8B1ED27Q33697388-53481875-1679-470F-B248-881543AF8E31Q34012450-85A99FB6-56DF-4AB4-8A5D-F27971CB2704Q34050994-3D1F1F36-0E83-46D7-AB5C-F7670B98EE7FQ34142092-E47CA805-7EAC-4DC3-AEAF-14E1F043DA88Q34297383-88BC9524-40B3-44FB-892E-C56CE0589019Q34523235-AD94294F-37EC-49A4-97FF-8999E14CC555Q34587326-464CBFAC-68CC-4B7E-853F-58AF0127D7E4Q34635239-1F76E13C-022F-4E26-8F38-FC38DFC596E3Q35124266-02A96BAE-AB99-450A-A549-0D930E9DA7A9Q35203400-415B7AB4-9D37-4CC7-B802-5AA1DB4B81D3Q35256633-0BB0A742-0F66-4795-93AE-C1B61122C5FAQ35422209-119FAF9B-0B56-419D-843A-D417BDA41BABQ35547522-0A98F15F-F245-47BD-B254-571DB3DEE89CQ35643796-96B561EE-02A2-4C2E-987B-23616AC462F4Q35707150-A572B535-E381-42F5-87D4-C978D339EE83Q35715763-7ACA75EE-3342-4C81-A99A-79AA9B9353B9Q35917516-B0B3C40C-E660-4EB2-819D-A260A0298AADQ35958480-65EB38FD-DEAC-4989-985D-1AFB9EB35EC2Q35964488-B416221C-0E12-417A-A4F3-E2EFD896E4F9Q36229809-B2DF325C-C676-45BB-85B3-CD8B67FCB4F5Q36303755-FAD06D8E-CD10-481D-9370-4E955531F121Q36371099-4ECADFEC-4AAF-460C-B321-10960ED91403Q36923664-FADD9AD5-97C8-4272-8587-D7C21779C3C9Q37353481-1165AFB1-C3D1-4C60-8A33-60C14150F916Q37579183-2FF8E66A-E495-4940-B3B3-CA6FAFB73167Q37715505-CBCCBD1D-3CE8-4BEF-ADBF-F9E66D6A79E9Q37940867-C28DF626-B4B6-4F5E-ACC9-DE44186B90B1Q38117018-EF31DB69-B1B6-40A0-A0EB-A624A25E708EQ38182323-876030F5-5BF0-4655-BC11-C602703E5D50Q38248789-B04FAF58-DF7F-40F1-8591-22C726E64105Q38863338-F5AA3C2F-2511-4D59-B2DD-87D2AB420372Q39183991-2BA6075D-38BD-4A68-A818-54EB93E4CB48Q39354612-8B4B7530-D15E-4EEB-9A56-1E5517E005C0Q39410103-5FE2E8EF-B806-4A36-A2F8-31A06345EEA4Q41217413-06BBB5CE-2D7B-40BE-B0E3-9C0A8B3667F5Q41659964-3DC655B0-1C6F-4BE2-A61C-1DF1B509BA89Q42053344-565B6786-04EC-4C44-8792-50F25396A03A
P2860
De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
De novo expression of podocyte ...... perimental glomerular disease.
@ast
De novo expression of podocyte ...... perimental glomerular disease.
@en
type
label
De novo expression of podocyte ...... perimental glomerular disease.
@ast
De novo expression of podocyte ...... perimental glomerular disease.
@en
prefLabel
De novo expression of podocyte ...... perimental glomerular disease.
@ast
De novo expression of podocyte ...... perimental glomerular disease.
@en
P2093
P2860
P1476
De novo expression of podocyte ...... perimental glomerular disease.
@en
P2093
Alice M Chang
Caroline B Marshall
Charles E Alpers
Jeffrey W Pippin
Kelly L Hudkins
Michael R Vaughan
Ronald D Krofft
Stuart J Shankland
Takamoto Ohse
P2860
P304
P356
10.1152/AJPRENAL.00428.2009
P577
2009-12-09T00:00:00Z